Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
205.64B
Market cap205.64B
Price-Earnings ratio
10.49
Price-Earnings ratio10.49
Dividend yield
2.75%
Dividend yield2.75%
Average volume
16.83M
Average volume16.83M
High today
$45.25
High today$45.25
Low today
$43.97
Low today$43.97
Open price
$44.63
Open price$44.63
Volume
15.40M
Volume15.40M
52 Week high
$81.44
52 Week high$81.44
52 Week low
$35.12
52 Week low$35.12

NVO News

The Motley Fool 2h
Eli Lilly Stock: Next Stop $2,000?

It's been a volatile year for Eli Lilly (LLY 1.61%). The company's shares trended lower through the end of April, dropping well below $900. However, the drugmak...

Eli Lilly Stock: Next Stop $2,000?
24/7 Wall St. 7h
Three Biotechs That Are Top Takeover Targets

Three Biotechs That Are Top Takeover Targets By Alex Sirois Published May 18, 1:55PM EDT Quick Read Viking Therapeutics (VKTX) has a dual GLP-1/GIP agonist in...

Three Biotechs That Are Top Takeover Targets
TipRanks 10h
Novo Nordisk Details Progress on DKK 15 Billion Share Buyback Programme

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

58%

of 36 ratings
Buy
33.3%
Hold
58.3%
Sell
8.3%

More NVO News

TipRanks 3d
Novo Nordisk’s Cagrilintide Trial Signals Next Wave in Obesity Treatment

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

TipRanks 3d
Novo Nordisk Expands Obesity Pipeline With AMAZE 6 Knee Osteoarthritis Trial

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

TipRanks 3d
Mixed options sentiment in Novo Nordisk with shares down 2.61%

Mixed options sentiment in Novo Nordisk (NVO), with shares down $1.20 near $44.60. Options volume relatively light with 26k contracts traded and calls leading p...

Nasdaq 3d
Buy, Sell, or Hold Novo Nordisk at $46?

Key Points The bulk of Novo Nordisk's sales come from weight-loss and diabetes treatments. The biotech faces competition from companies like Eli Lilly and Pfi...

Buy, Sell, or Hold Novo Nordisk at $46?
Simply Wall St 4d
Novo Nordisk Valuation Check After Mixed Year To Date And 1 Year Share Returns

Advertisement Recent share performance and business profile Novo Nordisk (NYSE:NVO) has drawn investor attention after a mixed stretch for the stock, with the...

Novo Nordisk Valuation Check After Mixed Year To Date And 1 Year Share Returns
Nasdaq 4d
Best Healthcare Stocks to Buy in 2026

Key Points Biogen will likely benefit from increased sales of its Alzheimer's therapy, Leqembi. Both companies have been active in acquisitions. Novo Nordisk...

Best Healthcare Stocks to Buy in 2026
The Motley Fool 5d
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?

Eli Lilly (LLY +2.61%) has become the leader in a market marching toward the $100 billion mark. I'm talking about the weight-loss drug market, expected to reach...

Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.